Luis Toro
Overview
Explore the profile of Luis Toro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Parra-Lucares A, Segura P, Rojas V, Pumarino C, Saint-Pierre G, Toro L
Life (Basel)
. 2022 Feb;
12(2).
PMID: 35207482
The COVID-19 pandemic has had a significant global impact, with more than 280,000,000 people infected and 5,400,000 deaths. The use of personal protective equipment and the anti-SARS-CoV-2 vaccination campaigns have...
12.
Parra-Lucares A, Toro L, Weitz-Munoz S, Ramos C
Viruses
. 2021 Dec;
13(12).
PMID: 34960761
The SARS-CoV-2 pandemic has mobilized many efforts worldwide to curb its impact on morbidity and mortality. Vaccination of the general population has resulted in the administration of more than 6,700,000,000...
13.
Pefaur J, Toro L, Lorca E, Torres R
Transplantation
. 2021 Nov;
106(4):680-684.
PMID: 34759256
No abstract available.
14.
Toro L, Zamorano P, Frias A, Parra-Lucares A, Silva M, Almeida P, et al.
Rev Med Chil
. 2021 Nov;
149(5):796-802.
PMID: 34751334
COVID-19 infection causes a systemic inflammatory response, which mainly presents as a febrile syndrome with respiratory involvement. We report a 37-year-old male who consulted for myalgia, nausea and epigastric pain...
15.
Gajardo M, Delucchi A, Perez D, Cancino J, Galvez C, Ledezma X, et al.
Pediatr Transplant
. 2021 Jul;
25(8):e14096.
PMID: 34327777
Background: Steroid use in renal transplant is related to multiple adverse effects. Long-term effects of early withdrawal steroids in pediatric renal transplant were assessed. Methods: Renal transplant children with low...
16.
Michea L, Toro L, Alban N, Contreras D, Morgado P, Paccot M, et al.
South Med J
. 2021 Feb;
114(2):63-69.
PMID: 33537784
Objectives: As part of the HEARTS in the Americas initiative, Chilean primary healthcare centers have implemented novel hypertension management strategies, including new diagnostic approaches. This study evaluated the concordance between...
17.
Toro L, Parra A, Alvo M
Rev Med Chil
. 2020 Jul;
148(4):558-560.
PMID: 32730468
No abstract available.
18.
Ivanovic-Zuvic D, Fischman A, Jimenez M, Martinez A, Ernst D, Toro L, et al.
Rev Med Chil
. 2020 Jul;
148(3):404-408.
PMID: 32730387
Hypophosphatemia is a relatively frequent and a potentially serious adverse drug effect. Clinically it is characterized by bone pain and muscle weakness. There are several mechanisms by which a drug...
19.
Delucchi A, Toro L, Alzamora R, Barrientos V, Gonzalez M, Andaur R, et al.
J Bone Miner Res
. 2019 May;
34(10):1851-1861.
PMID: 31099911
Renal transplantation (RTx) is an effective therapy to improve clinical outcomes in pediatric patients with terminal chronic kidney disease. However, chronic immunosuppression with glucocorticoids (GCs) reduces bone growth and BMD....
20.
Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
Toro L, Barrientos V, Leon P, Rojas M, Gonzalez M, Gonzalez-Ibanez A, et al.
Kidney Int
. 2018 Feb;
93(5):1131-1141.
PMID: 29395333
It is accepted that osteoblasts/osteocytes are the major source for circulating fibroblast growth factor 23 (FGF23). However, erythropoietic cells of bone marrow also express FGF23. The modulation of FGF23 expression...